person

Angel Michael O.

Country
Spain
Department
Endocrinología y Nutrición

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
42
Sites with multiple studies

Has run more than one trial at 42 of 417 partner sites.

Specializations

Lipid Disorders

This investigator specializes in the treatment of severe hypertriglyceridemia (SHTG) and related metabolic disorders, focusing on innovative therapeutic approaches for managing elevated triglyceride levels.

  • Lipid metabolism disorders
  • Triglyceride regulation
  • Metabolic disease management

The research encompasses various therapeutic interventions targeting triglyceride reduction in patients with severe metabolic conditions.

Novel Therapeutics

Active involvement in evaluating emerging treatments including olezarsen and plozasiran for metabolic disorders, with particular attention to their safety and efficacy profiles.

  • Innovative drug development
  • Therapeutic assessment
  • Clinical efficacy evaluation

The investigator focuses on advancing treatment options for patients with severe lipid disorders through targeted therapeutic approaches.

Metabolic Medicine

Expertise in treating various forms of hypertriglyceridemia, from moderate to severe presentations, with emphasis on understanding treatment responses and patient outcomes.

  • Metabolic disorder management
  • Lipid level monitoring
  • Treatment optimization

The work involves comprehensive assessment of metabolic parameters and therapeutic interventions in lipid disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.